Suppr超能文献

自从美国常规接种水痘疫苗以来,与水痘相关的门诊就诊和住院治疗有所减少。

Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella.

机构信息

Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

出版信息

Pediatr Infect Dis J. 2010 Mar;29(3):199-204. doi: 10.1097/INF.0b013e3181bbf2a0.

Abstract

BACKGROUND

Widespread varicella vaccination has led to substantial decreases in varicella-related mortality and hospitalizations. The effect of the vaccine on ambulatory care utilization is poorly defined.

OBJECTIVE

To determine trends in varicella-related ambulatory care and hospital discharges before and after vaccine licensure.

DESIGN, SETTING, AND PARTICIPANTS: Estimates of varicella-related ambulatory and hospital discharges were calculated for the pre- (1993-1995) and post- (1996-2004) vaccine licensure periods using the National Ambulatory Medical Care Survey, National Hospital Ambulatory Medical Care Survey, and National Hospital Discharge Survey.

MAIN OUTCOME MEASURE

Ambulatory and hospital discharge rates for varicella.

RESULTS

The rate of varicella-related ambulatory discharges decreased by 66% from 106.6 per 100,000 (95% confidence interval [CI]: 80.5-132.6) in the prelicensure period to 36.4 per 100,000 population (95% CI: 29.3-43.5) in the post-licensure period (P < 0.001). The decrease was significant across all age groups <45 years, with the greatest reduction (98%) occurring among patients 0 to 4 years of age. The incidence of varicella-related hospital discharges decreased by 53% from 30.9 per 100,000 (95% CI: 24.4-37.3) to 14.5 per 100,000 population (95% CI: 12.1-16.8; P < 0.001). This difference was significant among patients <14 years of age. Rates of varicella-related ambulatory discharges decreased significantly for both whites and non-whites in the postlicensure period, but postlicensure ambulatory discharge rates remained higher for non-whites than for whites. Decreases in varicella-related hospital discharges were statistically significant for whites and non-whites. Racial differences in the incidence of varicella-related hospital discharges also persisted following vaccine licensure.

CONCLUSIONS

Varicella-related ambulatory visits and hospitalizations have decreased significantly in the period after licensure of the varicella vaccine.

摘要

背景

广泛的水痘疫苗接种导致与水痘相关的死亡率和住院率大幅下降。疫苗对门诊护理利用的影响还没有明确的定论。

目的

确定疫苗获得许可前后与水痘相关的门诊护理和住院出院趋势。

设计、地点和参与者:使用国家门诊医疗调查、国家医院门诊医疗调查和国家医院出院调查,计算疫苗获得许可前(1993-1995 年)和后(1996-2004 年)两个时期与水痘相关的门诊和住院出院率。

主要观察指标

水痘相关的门诊和住院出院率。

结果

与水痘相关的门诊出院率从获得许可前的每 10 万人 106.6 例(95%置信区间:80.5-132.6)下降了 66%,至获得许可后的每 10 万人 36.4 例(95%置信区间:29.3-43.5)(P < 0.001)。所有<45 岁的年龄组都显著下降,其中 0 至 4 岁的患者降幅最大(98%)。与水痘相关的医院出院率下降了 53%,从每 10 万人 30.9 例(95%置信区间:24.4-37.3)降至每 10 万人 14.5 例(95%置信区间:12.1-16.8;P < 0.001)。这一差异在<14 岁的患者中显著。获得许可后,白人患者和非白人患者的与水痘相关的门诊出院率均显著下降,但非白人患者的门诊出院率仍高于白人患者。与水痘相关的医院出院率下降在白人患者和非白人患者中均具有统计学意义。疫苗获得许可后,与水痘相关的医院出院率的种族差异仍然存在。

结论

水痘疫苗获得许可后,与水痘相关的门诊就诊和住院治疗显著减少。

相似文献

2
Varicella-related hospitalizations in the vaccine era.疫苗时代与水痘相关的住院情况。
Pediatr Infect Dis J. 2002 Oct;21(10):927-31. doi: 10.1097/00006454-200210000-00008.
9
Hospitalizations for varicella in the United States, 1988 to 1999.1988年至1999年美国水痘住院情况。
Pediatr Infect Dis J. 2002 Oct;21(10):931-5. doi: 10.1097/00006454-200210000-00009.

引用本文的文献

5
Global impact of varicella vaccination programs.全球水痘疫苗接种计划的影响。
Hum Vaccin Immunother. 2019;15(3):645-657. doi: 10.1080/21645515.2018.1546525. Epub 2018 Dec 10.
6
Varicella vaccination - the global experience.水痘疫苗——全球经验
Expert Rev Vaccines. 2017 Aug;16(8):833-843. doi: 10.1080/14760584.2017.1343669. Epub 2017 Jul 13.
8
Efficacy of varicella (VZV) vaccination: an update for the clinician.水痘(VZV)疫苗的疗效:给临床医生的最新信息
Ther Adv Vaccines. 2016 Jan;4(1-2):20-31. doi: 10.1177/2051013616655980. Epub 2016 Jan 1.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验